Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes

Area of Science:

• Biotechnology
• Nanomedicine
• Drug Delivery Systems

Background:

• Liposomes are susceptible to rapid clearance by the mononuclear phagocytic system (MPS).
• Poly(ethylene glycol) (PEG) derivatization of lipids is a strategy to improve liposome circulation time.
• Understanding the structure-function relationship of PEG-derivatized phosphatidylethanolamine (PEG-PE) is crucial for optimizing liposome formulations.

Purpose of the Study:

• To investigate the structure-function relationship of PEG-PE in liposomes.
• To evaluate the impact of PEG-PE on liposome blood lifetime and tissue distribution.
• To determine the optimal molecular weight range of PEG for enhanced liposome performance.

Main Methods:

• Liposomes were formulated with phosphatidylcholine (PC), cholesterol, and varying amounts of PEG-PE.
• Blood lifetime and tissue distribution studies were conducted in mice and rats.
• The molecular weight of PEG was varied within the range of 1000 to 5000 Da.

Main Results:

• Liposomes containing 7.5 mol% PEG-PE with PEG molecular weights of 1000-5000 Da exhibited prolonged circulation.
• Up to 35% of the injected dose remained in circulation after 24 hours, compared to 1% for non-PEGylated liposomes.
• MPS uptake was reduced to less than 10% with PEG-PE, versus 40% for conventional liposomes.
• PEG-PE's efficacy was independent of cholesterol, lipid saturation, lipid dose, or the addition of other lipids.

Conclusions:

• PEG-PE significantly enhances liposome circulation time and reduces MPS uptake.
• The molecular weight of PEG is a key factor in achieving prolonged liposome circulation.
• PEG-PE offers versatility in liposome formulation, essential for controlling drug dosage and release in therapeutic applications.